All terms in DOID
| Label | Id | Description |
|---|---|---|
| wybutosine | SO_0001332 | [Wybutosine is a modified guanosine base feature.] |
| APP-related cerebral amyloid angiopathy | DOID_0070028 | [A cerebral amyloid angiopathy that has_material_basis_in an autosomal dominant mutation of APP on chromosome 21q21.3.] |
| cerebral amyloid angiopathy | DOID_9246 | [An amyloidosis where amyloid protein progressively deposits in cerebral blood vessel walls with subsequent degenerative vascular changes that usually result in spontaneous cerebral hemorrhage, ischemic lesions and progressive dementia.] |
| two_prime_O_ribosylguanosine_phosphate | SO_0001331 | [2prime_O_ribosylguanosine_phosphate is a modified guanosine base feature.] |
| ITM2B-related cerebral amyloid angiopathy 1 | DOID_0070029 | [A cerebral amyloid angiopathy characterized by onset in the 4th to 6th decade of life, progressive mental deterioration, spasticity, muscular rigidity but no tremors, spontaneous movements or sensory changes that has_material_basis_in an autosomal dominant mutation of ITM2B on chromosome 13q14.2.] |
| N2_N2_2_prime_O_trimethylguanosine | SO_0001330 | [N2_N2_2prime_O_trimethylguanosine is a modified guanosine base feature.] |
| Revesz syndrome | DOID_0070026 | [A dyskeratosis congenita that has_material_basis_in a mutation of TINF2 on chromosome 14q12.] |
| CST3-related cerebral amyloid angiopathy | DOID_0070027 | [A cerebral amyloid angiopathy that has_material_basis_in an autosomal dominant mutation of CST3 on chromosome 20p11.21.] |
| autosomal recessive dyskeratosis congenita 6 | DOID_0070024 | [A dyskeratosis congenita that has_material_basis_in an autosomal recessive mutation of PARN on chromosome 16p13.12.] |
| X-linked dyskeratosis congenita | DOID_0070025 | [A dyskeratosis congenita that has_material_basis_in an X-linked recessive mutation of DKC1 on chromosome Xq28.] |
| aztreonam | CHEBI_161680 | [A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.] |
| monobactam | CHEBI_50695 | [Monocyclic, bacterially produced or semisynthetic beta-lactam antibiotic. It lacks the double ring construction of the traditional beta-lactam antibiotics and can be easily synthesized.] |
| autosomal dominant non-syndromic intellectual disability 3 | DOID_0070033 | [An autosomal dominant non-syndromic intellectual disability that has_material_basis_in an autosomal dominant mutation of CDH15 on chromosome 16q24.3.] |
| galactosyl_queuosine | SO_0001319 | [Galactosyl_queuosine is a modified 7-deazoguanosine.] |
| autosomal dominant non-syndromic intellectual disability 4 | DOID_0070034 | [An autosomal dominant non-syndromic intellectual disability that has_material_basis_in an autosomal dominant mutation of KIRREL3 on chromosome 11q24.2.] |
| epoxyqueuosine | SO_0001318 | [Epoxyqueuosine is a modified 7-deazoguanosine.] |
| autosomal dominant non-syndromic intellectual disability 1 | DOID_0070031 | [An autosomal dominant non-syndromic intellectual disability that has_material_basis_in an autosomal dominant mutation of MBD5 on chromosome 2q23.1.] |
| queuosine | SO_0001317 | [Queuosine is a modified 7-deazoguanosine.] |
| autosomal dominant non-syndromic intellectual disability 2 | DOID_0070032 | [An autosomal dominant non-syndromic intellectual disability that has_material_basis_in an autosomal dominant mutation of DOCK8 on chromosome 9p24.] |
| N6_acetyladenosine | SO_0001315 | [N6_acetyladenosine is a modified adenosine.] |